Memorial Sloan Kettering Cancer Center: Neoplasms trials

The registry lists 95 Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 14 are open to participants now and 18 have results posted.

Early Phase 1 1Phase 1 37Phase 2 21Phase 3 4No phase 35(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Vaping Use Among Adolescent and Young Adult Patients With CancerEnrolling by invitationNCT07860801
• Improving Goals of Care Conversations Between Doctors and Young Adults With CancerEnrolling by invitationNCT07855484Not applicable
• A Study of Music Therapy for Anxiety in People With CancerRecruitingNCT07845422Not applicable
• A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to HealthcareRecruitingNCT07780903
• Study of a Support Program for Quality of Life in Chinese Cancer Patients and SurvivorsRecruitingNCT07454330Not applicable
• A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their PainRecruitingNCT07447856Phase 1
• A Study of Herbal Supplements in Cancer Survivors With ConstipationRecruitingNCT07091084Not applicable
• Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer SurvivorsRecruitingNCT07030686
• Acupuncture for People Experiencing Period Loss Due to ChemotherapyRecruitingNCT06915116Phase 2
• An Acupuncture Study for Cancer Survivors With Joint PainRecruitingNCT06814977Not applicable
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerRecruitingNCT05859074Phase 1
• A New Psychotherapy Intervention for Older Cancer PatientsRecruitingNCT04452825Not applicable
• Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of CancerRecruitingNCT03922893
• Impact of ICCAN on Cancer Treatment Completion and Quality of LifeRecruitingNCT01742143
• A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid TumorsTerminatedNCT04671901Phase 2Results posted
• A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative ResectionTerminatedNCT04510285Phase 2Results posted
• Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic MalignanciesCompletedNCT03082677Phase 2Results posted
• Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile InfectionCompletedNCT02770326Not applicableResults posted
• Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic MalignanciesCompletedNCT02340728Phase 3Results posted
• Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related MalignanciesCompletedNCT02308241Not applicableResults posted
• Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid TumorsCompletedNCT02281409Phase 1/2Results posted
• Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)CompletedNCT00610129Phase 2Results posted
• Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated DonorCompletedNCT00582933Phase 2Results posted
• Prospective Trial of Vaccine Responses in Childhood Cancer SurvivorsCompletedNCT00505063Phase 2Results posted
• Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsCompletedNCT00470366Phase 2Results posted
• Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00453310Phase 2Results posted
• Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to CisplatinCompletedNCT00423852Phase 1/2Results posted
• Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
• A Randomized Study of Sulindac in Oral Premalignant LesionsCompletedNCT00299195Not applicableResults posted
• Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerCompletedNCT00027560Phase 2Results posted
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsCompletedNCT00024258Phase 2Results posted
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell TumorsCompletedNCT00002558Phase 1/2Results posted
• COBRA: Cancer, Older Adults, Balance and Resistance ActivitiesActive, not recruitingNCT07011862Not applicable
• A Study of Exercise Therapy in People With Solid Tumor CancerWithdrawnNCT06597786Phase 1
• A Study of Avutometinib for People With Solid Tumor CancersActive, not recruitingNCT06104488Phase 1
• A Study of N9 Chemotherapy in Children With NeuroblastomaActive, not recruitingNCT04947501Early Phase 1
• A Study of a Telemedicine Program for Older Adults With CancerActive, not recruitingNCT04917848Not applicable
• Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer SurvivorsActive, not recruitingNCT04916249Phase 2
• Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19CompletedNCT04824443Phase 1
• A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 MalignanciesWithdrawnNCT04556266Phase 1
• Psychotherapy Intervention for Latinos With Adv CancerActive, not recruitingNCT04537936Not applicable
• Supportive Care Delivered by Telemedicine to Cancer Patients at HomeCompletedNCT04136340Not applicable
• Psychotherapy Intervention for Latinos With Advanced CancerActive, not recruitingNCT04015609Not applicable
• Researching the Effect of Aerobic Exercise on CancerActive, not recruitingNCT03996239Not applicable
• Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated MalignanciesWithdrawnNCT03988582Phase 2
• AZD5363 in Patients With Advanced Solid Tumors Harboring AKT MutationsCompletedNCT03310541Phase 1
• Understanding the Late Effects of Surviving a Pediatric Brain TumorActive, not recruitingNCT03208387
• Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular ProfilingActive, not recruitingNCT03208374
• Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their CaregiversCompletedNCT03168971Not applicable
• Imaging With a New Agent That Finds a Cancer Protein Called HER2CompletedNCT03109977Phase 1
• Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheetCompletedNCT02902107Phase 1
• Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL InstrumentsCompletedNCT02296450
• Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to TherapyWithdrawnNCT02139150Not applicable
• Promoting Breast Cancer Screening in Women Who Survived Childhood CancerActive, not recruitingNCT01579552Phase 3
• The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver MetastasesCompletedNCT01423734
• The First-in-human Phase I Trial of PU-H71 in Patients With Advanced MalignanciesCompletedNCT01393509Phase 1
• Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid TumorsCompletedNCT01379287Phase 1
• BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid TumorsCompletedNCT01297452Phase 1
• Perifosine With Temsirolimus for Recurrent Pediatric Solid TumorsCompletedNCT01049841Phase 1
• Study of Radiation Exposure and Bilateral Breast CancerActive, not recruitingNCT00903591
• Adolescent and Young Adult Cancer Survivors: Identity DevelopmentActive, not recruitingNCT00832325
• Study of Single Agent Perifosine for Recurrent Pediatric Solid TumorsCompletedNCT00776867Phase 1
• Quality of Life in Patients Undergoing Total Pelvic ExenterationCompletedNCT00597805
• Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)CompletedNCT00591643Phase 1
• Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATACompletedNCT00588289
• Estrogen, Diet, Genetics and Endometrial CancerActive, not recruitingNCT00587886
• Trial of Family Focused Grief Therapy in Palliative Care and BereavementCompletedNCT00580515Not applicable
• Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine TumorsCompletedNCT00580463
• Lung Cancer Informational Study (LCIS)CompletedNCT00579215Not applicable
• Cisplatin and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00423865Phase 1
• Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell TransplantationCompletedNCT00138112Phase 3
• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704
• Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00084812Phase 1
• Gefitinib and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00084786Phase 1
• Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell TumorsCompletedNCT00070096Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00045448Phase 1
• BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00043095Phase 1
• Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT00027638Phase 2
• 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid TumorsCompletedNCT00024245Phase 1
• Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid TumorsCompletedNCT00014378Phase 1
• Ro 31-7453 in Treating Patients With Metastatic Solid TumorsCompletedNCT00014365Phase 1
• Flavopiridol and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNCT00006485Phase 1
• LY293111 in Treating Patients With Advanced Solid TumorsCompletedNCT00006375Phase 1
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00005791Phase 1
• ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004926Phase 1
• Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid TumorsCompletedNCT00004059Phase 1
• Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid TumorCompletedNCT00003755Phase 1
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00003742Phase 1
• Arsenic Trioxide in Treating Patients With Advanced Solid TumorsCompletedNCT00003630Phase 1
• Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00003242Phase 1
• Green Tea Extract in Treating Patients With Advanced Solid TumorsCompletedNCT00003197Phase 1
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsCompletedNCT00003173Phase 2
• Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid TumorsCompletedNCT00003004Phase 1
• Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell TumorsCompletedNCT00002596Phase 3
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerCompletedNCT00002515Phase 2